Bio-IT World July 29, 2019
Deborah Borfitz

Natural language processing (NLP) is finding novel applications at Novo Nordisk, turning a trio of real-world data (RWD) sources into a goldmine of knowledge about the medicines it makes, the healthcare providers who prescribe them, and patients who usually pay for a portion of the cost. Novo Nordisk leverages the NLP text-mining tool of Linguamatics to create efficiencies and generate actionable insights enterprise-wide, winning the company an Innovative Practices Award at the recent Bio-IT World Conference & Expo ’19 in Boston.

NLP is most typically used within the life sciences industry to select targets for the drug discovery process, according to Thierry Breyette, associate director of information analytics at Novo Nordisk. Some companies have also begun using NLP to assist...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Analytics, Big Data, Technology
The AI frenzy could fall flat as companies hoard chips without enough data centers to host them
Infographic: 4 Areas Where AI Is Impacting Health Systems
Moderna turns to AI to change how its employees work
AI may be useful in polypharmacy management
Manatt Launches Health AI Policy Tracker

Share This Article